Transfusion Diagnostics market is hefty impacted by demand for blood supply, however the global suffer a decrease in blood supply in 2014 and 2015.

Transfusion Diagnostics market is mature in comparison to the other medical services, market sales arises from the blood grouping and typing segment and the disease screening (serological and NAT methods) segment. NAT methods are still evolving and contribute only 6.9 % to the disease screening market.

Global Transfusion Diagnostics market is estimated to have revenues of 28.4 $Billion in 2016 and an expectation to reach 32.1 $Billion by 2020 with a CAGR of 4.32% during the forecast period 2016-2020. In terms of geographic, the North America dominate the market followed by ACPC, and Asia is expected to register the highest growth rate over 2016-2020.

According to research, there many sites are still using manual methods for blood typing; this market has a huge scope for automation.

The molecular immunohematology segment is rising rapidly, particularly because hemagglutination methods are exhibiting problems. Considering the FDA has been quite slow in approving tests for IVD use, Immucor will dominate this market until its peers, such as Grifols, join the market in 2016.

Supply chain is becoming an important component of blood banks, and several companies such as Haemonetics, Cerner, and Mediware are gaining importance. One of the persistent problems associated with automating the blood banking workflow is the interconnectivity with HIS and LIS applications.

Read Full Report: http://www.gosreports.com/global-transfusion-diagnostics-industry-2016-market-research-report/

Joanna | Executive – International Business and partner Relations
E-mail: [email protected] | Tel: 1-510-400-8520
Web: www.gosreports.com